Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration

BACKGROUND: The aim of this study is to analyze mortality in patients treated with bevacizumab for wet AMD. METHODS: We conducted a retrospective case-control study between patients who received intravitreal injections of bevacizumab as the sole treatment for exudative AMD between September 2008 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanhart, Joel, Comaneshter, Doron S., Freier Dror, Yossi, Vinker, Shlomo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635499/
https://www.ncbi.nlm.nih.gov/pubmed/29017506
http://dx.doi.org/10.1186/s12886-017-0586-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635499/
https://www.ncbi.nlm.nih.gov/pubmed/29017506
http://dx.doi.org/10.1186/s12886-017-0586-0

Ejemplares similares